News
A U.S. government scientist who oversees the team responsible for collecting data on COVID-19 and RSV hospitalizations used ...
For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.
The 17 members of the CDC's vaccine advisory committee, who were ousted last week, argued their abrupt dismissal has "left ...
11h
India Today on MSNWhy RSV prevention for infants is still years away in IndiaRespiratory Syncytial Virus is a growing health concern for Indian infants. Efforts for maternal RSV vaccine faces challenges ...
Fiona Havers, who oversees CDC respiratory virus data, told colleagues she no longer had confidence the data would be used ...
Tourists in Israel and Lebanon have found themselves stranded at airports amid Israel's conflict with Iran. Fiona Jones ...
Explore more
A major study presented today at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated ...
The incidence of RSV across 5 respiratory virus seasons was substantial among adult patients with high-risk underlying conditions.
All 17 experts recently dismissed from a government vaccine advisory panel published an essay Monday decrying “destabilizing ...
6h
Zacks Investment Research on MSNEMA Accepts GSK's Filing for Expanded Use of RSV Vaccine ArexvyGSK plc GSK announced that the European Medicines Agency (EMA) has accepted the regulatory application seeking approval to ...
CHARLOTTE — Whitney Hamilton says her 4-year-old son, Elijah, is always happy, but his life dramatically changed in February ...
A Seattle infectious disease doctor, whose work was pivotal early in the COVID pandemic, shares more on her experience with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results